Efficacy of Myo-inositol on microinjectio
Phase 1
- Conditions
- Female infertility.Female infertility
- Registration Number
- IRCT20180417039338N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Women aged 20-40 years
with Polycystic ovary syndrome
with oligomenorrhea cycles
FSH levels <10
no hormonal treatment during the last 6 months
Exclusion Criteria
with endometriosis
History of oophorectomy
Age over 40 and under 20 years
women with infertility due to male factor
BMI <17 or BMI> 30
Endocrine diseases such as hyperprolactinemia, thyroid dysfunction, adrenal insufficiency and Cushing's disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of Oocytes. Timepoint: On the oocyte collection day. Method of measurement: Using ovulation test kits.;Oocyte quality. Timepoint: On the oocyte collection day. Method of measurement: Morphologic assesment with microscope.
- Secondary Outcome Measures
Name Time Method umber of embryos. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: Morphologic assesment with microscope.;Embryo quality. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: Morphologic assesment with microscope.;Fertilization rate. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: (embros number/injected oocytes numbers) * 100.